Semaglutide use in patients with type 2 diabetes moderately increases the risk of nonarteritic anterior ischemic optic neuropathy.
A recent review and meta-analysis of semaglutide studies found that this drug can significantly reduce the risk of ...
Adults with type 2 diabetes may have a higher risk for developing nonarteritic anterior ischemic optic neuropathy while using ...
This article showcases a curated list of standout studies over the last week on topics such as cholesterol, GLP-1 drugs for ...
Small studies link Ozempic and similar drugs to rare but serious eye conditions. However, experts say there's no need to ...
GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.
The case for GLP-1 drugs like Ozempic possibly causing blindness is building. A new paper out this week describes several people who developed eye conditions soon after they began taking semaglutide ...
Ozempic made headlines after a study came out linking this and similar medications like Wegovy to an eye condition that can ...
A new study adds to a growing body of research suggesting a potential link between popular GLP-1 medications like Ozempic and ...
Although reports of vision problems with weight loss drugs are still rare, researchers say there is cause for concern because ...
Symptoms of NAION can include blurred vision, peripheral vision loss, dark spots in vision, and changes in color perception. Though the exact mechanism is not fully understood, researchers hypothesize ...
Health experts are investigating a possible link between popular weight loss drugs like Ozempic and sudden blindness.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results